variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
GPD1L-I124V,GPD1L,"Found in a single SIDS case (out of 304 total cases). Although the authors described a functional impact of the variant in cell lines, the findings in human subjects did not have statistical significance and there is currently no clinical testing for variants in this gene.",High,Uncertain,Pathogenic,0.0011,Other,Dominant,Heterozygous,17967976,rs72552293,4,chr3,32181723,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
BTD-A171T,BTD,"This variant, which has always been reported as occurring with the D444H variant, is implicated in causing biotinidase deficiency. The double-mutant appears to abolish enzyme activity, but there is a report of homozygous asymptomatic adults with profound biotinidase deficiency (symptoms may depend on additional factors). This double-variant (A171T and D444H) has been observed to cause deficiency in a compound heterozygous fashion when paired with another, more severe mutation.",Moderate,Likely,Pathogenic,0.00028,Metabolism,Recessive,Heterozygous,88555;2109151;9375914;10206677;18704161,,3,chr3,15685874,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
BTD-D444H,BTD,"This variant is implicated in partial and profound biotinidase deficiency. Alone, this variant is estimated to have a 52% loss of enzymatic activity. This variant is often found with A171T, and together they are reported to cause profound deficiency. Notably there is a report of asymptomatic double-mutant adults, so symptoms may have variable penetrance. This variant is found compound heterozygously with more serious mutations in cases of partial biotinidase deficiency.",Low,Well-established,Pathogenic,0.03,Metabolism,Recessive,Heterozygous,88555;2109151;9375914;9654207;10206677;18704161,rs13078881,1,chr3,15686693,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
PRF1-A91V,PRF1,"This variant may be associated with a slightly increased susceptibility to some rare blood disorders, in particular autoimmune proliferative disease, if combined with a more severe mutation elsewhere. Most reports lack statistical significance.",Low,Likely,Pathogenic,0.033,Blood;Immune system,Complex/Other,Heterozygous,16720836;17311987;17475905,rs35947132,1,chr10,72360387,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
CETP-A390P,CETP,"This variant is associated with slightly lower HDL (good) cholesterol, although it has a negligible effect (around 2 mg/dl).",Low,Likely,Pathogenic,0.039,Metabolism,Unknown,Heterozygous,17952847,rs5880,1,chr16,57015091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Homozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
PRODH-R453C,PRODH,"Associated with reduced proline oxidase activity, and may cause hyperprolemia in a recessive manner (when homozygous or compound heterozygous). Hyperprolemia, in turn, may be associated with schizophrenia.",Low,Uncertain,Pathogenic,0.01,Mental and behavioral,Recessive,Heterozygous,12217952;15662599,rs3970559,1,chr22,18905899,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
RET-Y791F,RET,"Several publications asserted this variant caused familial medullary thyroid cancer in a dominant manner. However, a 2010 publication by Erlic et al. examined a larger set of controls, finding the variant no more common in cases than it was in controls. These authors conclude that the variant is not a serious cause of the disease, although they could not rule out a small effect on risk.",Low,Uncertain,Pathogenic,0.0013,Cancer,Unknown,Heterozygous,9506724;12000816;12409662;15531714;15870131;16118333;16705552;19826964;19906784,,0,chr10,43613908,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Homozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
ADA-D8N,ADA,"This common variant is reported to reduce adenosine deaminase enzyme activity. It has been associated with an increased tendency for non-REM sleep -- more slow wave sleep, less nocturnal wakings, and a stronger negative impact of sleep deprivation. A role for this gene and variant was previously proposed for autism susceptibility, but this is controversial and was not replicated by later studies.",Low,Likely,Benign,0.03,Nervous system,Dominant,Heterozygous,7316475;8031011;11354825;16221767;17340203;21359089;21734253,rs73598374,,chr20,43280227,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Heterozygous,11292664,rs34221241,,chr5,180057293,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TXNDC3-I338T,TXNDC3,"Tentatively classified as benign, but predicted to be damaging and other variants in this gene are implicated in causing primary ciliary dyskinesia (situs inversus, chronic sinusitis, and bronchiectasis).",Low,Uncertain,Benign,0.038,Anatomical and congenital;Breathing,Unknown,Heterozygous,,rs62001870,,chr7,37923923,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
NEUROD1-P197H,NEUROD1,"Tentatively presumed benign. Other disruptive mutations in this gene have been reported to cause type 2 diabetes in a dominant manner, but this was found in a PGP participant who does not report having the disease.",Low,Uncertain,Benign,0.02,Metabolism,Unknown,Heterozygous,10545951,rs8192556,,chr2,182542998,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
F5-M413T,F5,Presumed benign. This variant is not particularly rare and has not been reported to cause disease.,Low,Uncertain,Benign,0.058,Other,Unknown,Heterozygous,17284699,rs6033,,chr1,169521853,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
F5-D2222G,F5,"Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.",Low,Uncertain,Benign,0.045,Blood,Unknown,Heterozygous,,rs6027,,chr1,169483561,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Heterozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Heterozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4a69389f2340495f1fe691b2f39c237d1d49b98e
